[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - A study conducted by the Federal University of São Paulo (UNIFESP) jointly with researchers from England and Italy, has pointed out a potential new action mechanism of the drug heparin, an anticoagulant, in the treatment of the coronavirus (covid-19).

In addition to inhibiting clotting disorders that can affect lung vessels and impair oxygenation, the drug also seems to be able to hinder the novel coronavirus from entering the cells. The researchers performed laboratory tests on cell lines from the kidneys of the African Vervet Monkey (Cercopithecus aethiops) and heparin reduced the invasion of cells . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?